Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
PAO Group, Inc. (OTC:PAOG), a holding company focused on alternative patient treatments, confirmed Friday it will launch a CBD Nutraceuticals line of products.
The company will create and sell new CBD nutraceuticals together with Alkame Holdings, Inc. (OTC:ALKM), which will take on the role of co-packer, and North American Cannabis Holdings, Inc. (OTC:USMJ) whose team will help with distribution services.
PAOG is currently working on a CBD pharmaceutical product called RespRx as therapy for chronic obstructive pulmonary disorder. The product is derived from a patented cannabis extraction method.
CBD Nutraceuticals is expected to generate revenue this year, as the first three products will be launched during the fourth quarter of 2021: